Search

Your search keyword '"Chng, Wee-Joo"' showing total 1,872 results
Start Over Author "Chng, Wee-Joo"
1,872 results on '"Chng, Wee-Joo"'

2. The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR)

Author

Aoki, Naomi, Chen, Pin-Yen, Chen, Wenming, Chng, Wee Joo, Gan, Gin Gin, Goh, Yeow Tee, Hou, Jian, Huang, Jeffrey, Kim, Kihyun, Lee, Je Jung, Lu, Jin, McQuilten, Zoe K., Min, Chang Ki, Moore, Elizabeth, Oliver, Laura, Waters, Neil A., Wellard, Cameron, Wood, Erica M., Yeh, Su-Peng, and Spencer, Andrew

Published
2024
Full Text
View/download PDF

6. Integrin-α9 overexpression underlies the niche-independent maintenance of leukemia stem cells in acute myeloid leukemia

Author

Niibori-Nambu, Akiko, Wang, Chelsia Qiuxia, Chin, Desmond Wai Loon, Chooi, Jing Yuan, Hosoi, Hiroki, Sonoki, Takashi, Tham, Cheng-Yong, Nah, Giselle Sek Suan, Cirovic, Branko, Tan, Darren Qiancheng, Takizawa, Hitoshi, Sashida, Goro, Goh, Yufen, Tng, Jiaqi, Fam, Wee Nih, Fullwood, Melissa Jane, Suda, Toshio, Yang, Henry, Tergaonkar, Vinay, Taniuchi, Ichiro, Li, Shang, Chng, Wee Joo, and Osato, Motomi

Published
2024
Full Text
View/download PDF

8. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group

Author

Gill, Harinder, Leung, Garret M. K., Ooi, Melissa G. M., Teo, Winnie Z. Y., Wong, Chieh-Lee, Choi, Chul Won, Wong, Gee-Chuan, Lao, Zhentang, Rojnuckarin, Ponlapat, Castillo, Ma. Rosario Irene D., Xiao, Zhijian, Hou, Hsin-An, Kuo, Ming-Chung, Shih, Lee-Yung, Gan, Gin-Gin, Lin, Chien-Chin, Chng, Wee-Joo, and Kwong, Yok-Lam

Published
2023
Full Text
View/download PDF

10. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D, Araujo, Iguaracyra Barreto de Oliveira, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John KC, Cheuk, Wah, Chng, Wee-Joo, Choi, John K, Chuang, Shih-Sung, Coupland, Sarah E, Czader, Magdalena, Dave, Sandeep S, de Jong, Daphne, Du, Ming-Qing, Elenitoba-Johnson, Kojo S, Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J, Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M, Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E, Kumar, Shaji, Lazar, Alexander J, Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S, Liu, Wei-Ping, Louissaint, Abner, Marcogliese, Andrea, Medeiros, L Jeffrey, Michal, Michael, Miranda, Roberto N, Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N, Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S Vincent, Rawstron, Andrew C, Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D, Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Subjects
Cancer, Hematologic Neoplasms, Humans, Lymphoma, World Health Organization, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.

Published
2022

11. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Author

Khoury, Joseph D, Solary, Eric, Abla, Oussama, Akkari, Yassmine, Alaggio, Rita, Apperley, Jane F, Bejar, Rafael, Berti, Emilio, Busque, Lambert, Chan, John KC, Chen, Weina, Chen, Xueyan, Chng, Wee-Joo, Choi, John K, Colmenero, Isabel, Coupland, Sarah E, Cross, Nicholas CP, De Jong, Daphne, Elghetany, M Tarek, Takahashi, Emiko, Emile, Jean-Francois, Ferry, Judith, Fogelstrand, Linda, Fontenay, Michaela, Germing, Ulrich, Gujral, Sumeet, Haferlach, Torsten, Harrison, Claire, Hodge, Jennelle C, Hu, Shimin, Jansen, Joop H, Kanagal-Shamanna, Rashmi, Kantarjian, Hagop M, Kratz, Christian P, Li, Xiao-Qiu, Lim, Megan S, Loeb, Keith, Loghavi, Sanam, Marcogliese, Andrea, Meshinchi, Soheil, Michaels, Phillip, Naresh, Kikkeri N, Natkunam, Yasodha, Nejati, Reza, Ott, German, Padron, Eric, Patel, Keyur P, Patkar, Nikhil, Picarsic, Jennifer, Platzbecker, Uwe, Roberts, Irene, Schuh, Anna, Sewell, William, Siebert, Reiner, Tembhare, Prashant, Tyner, Jeffrey, Verstovsek, Srdan, Wang, Wei, Wood, Brent, Xiao, Wenbin, Yeung, Cecilia, and Hochhaus, Andreas

Subjects
Genetics, Human Genome, 4.1 Discovery and preclinical testing of markers and technologies, Detection, screening and diagnosis, Hematologic Neoplasms, Histiocytosis, Humans, World Health Organization, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms and provides an overview of the principles and rationale underpinning changes from the prior edition. The definition and diagnosis of disease types continues to be based on multiple clinicopathologic parameters, but with refinement of diagnostic criteria and emphasis on therapeutically and/or prognostically actionable biomarkers. While a genetic basis for defining diseases is sought where possible, the classification strives to keep practical worldwide applicability in perspective. The result is an enhanced, contemporary, evidence-based classification of myeloid and histiocytic/dendritic neoplasms, rooted in molecular biology and an organizational structure that permits future scalability as new discoveries continue to inexorably inform future editions.

Published
2022

12. Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia

Author

Ong, Kelly Ooi Kee, Mok, Michelle Meng Huang, Niibori-Nambu, Akiko, Du, Linsen, Yanagida, Masatoshi, Wang, Chelsia Qiuxia, Bahirvani, Avinash Govind, Chin, Desmond Wai Loon, Koh, Cai Ping, Ng, King Pan, Yamashita, Namiko, Jacob, Bindya, Yokomizo, Tomomasa, Takizawa, Hitoshi, Matsumura, Takayoshi, Suda, Toshio, Lau, Jie-ying Amelia, Tan, Tuan Zea, Mori, Seiichi, Yang, Henry, Iwasaki, Masayuki, Minami, Takashi, Asou, Norio, Sun, Qiao-Yang, Ding, Ling-Wen, Koeffler, H. Phillip, Tenen, Daniel G., Shimizu, Ritsuko, Yamamoto, Masayuki, Ito, Yoshiaki, Kham, Shirley Kow Yin, Yeoh, Allen Eng-Juh, Chng, Wee Joo, and Osato, Motomi

Published
2024
Full Text
View/download PDF

14. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D., de Oliveira Araujo, Iguaracyra Barreto, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John K. C., Cheuk, Wah, Chng, Wee-Joo, Choi, John K., Chuang, Shih-Sung, Coupland, Sarah E., Czader, Magdalena, Dave, Sandeep S., de Jong, Daphne, Di Napoli, Arianna, Du, Ming-Qing, Elenitoba-Johnson, Kojo S., Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J., Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M., Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E., Kumar, Shaji, Lazar, Alexander J., Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S., Liu, Wei-Ping, Louissaint, Jr, Abner, Marcogliese, Andrea, Medeiros, L. Jeffrey, Michal, Michael, Miranda, Roberto N., Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N., Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S. Vincent, Rawstron, Andrew C., Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R., Suzuki, Ritsuro, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D., Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Published
2023
Full Text
View/download PDF

15. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Author

Rodriguez-Otero, Paula, Usmani, Saad, Cohen, Adam D, van de Donk, Niels W C J, Leleu, Xavier, Gállego Pérez-Larraya, Jaime, Manier, Salomon, Nooka, Ajay K, Mateos, Maria Victoria, Einsele, Hermann, Minnema, Monique, Cavo, Michele, Derman, Benjamin A, Puig, Noemi, Gay, Francesca, Ho, P Joy, Chng, Wee-Joo, Kastritis, Efstathios, Gahrton, Gösta, Weisel, Katja, Nagarajan, Chandramouli, Schjesvold, Fredik, Mikhael, Joseph, Costa, Luciano, Raje, Noopur S, Zamagni, Elena, Hájek, Roman, Weinhold, Niels, Yong, Kwee, Ye, Jing Christine, Sidhana, Surbhi, Merlini, Giampaolo, Martin, Tom, Lin, Yi, Chari, Ajai, Popat, Rakesh, and Kaufman, Jonathan L

Published
2024
Full Text
View/download PDF

21. Enabling Technologies for Personalized and Precision Medicine

Author

Ho, Dean, Quake, Stephen R, McCabe, Edward RB, Chng, Wee Joo, Chow, Edward K, Ding, Xianting, Gelb, Bruce D, Ginsburg, Geoffrey S, Hassenstab, Jason, Ho, Chih-Ming, Mobley, William C, Nolan, Garry P, Rosen, Steven T, Tan, Patrick, Yen, Yun, and Zarrinpar, Ali

Subjects
Bioengineering, Brain Disorders, Clinical Research, Generic health relevance, Good Health and Well Being, Artificial Intelligence, Biomarkers, Diagnosis, Humans, Precision Medicine, Therapeutics, artificial intelligence, clinical trials, diagnostics, personalized medicine, precision medicine, therapeutics, Biological Sciences, Engineering, Technology, Biotechnology
Abstract

Individualizing patient treatment is a core objective of the medical field. Reaching this objective has been elusive owing to the complex set of factors contributing to both disease and health; many factors, from genes to proteins, remain unknown in their role in human physiology. Accurately diagnosing, monitoring, and treating disorders requires advances in biomarker discovery, the subsequent development of accurate signatures that correspond with dynamic disease states, as well as therapeutic interventions that can be continuously optimized and modulated for dose and drug selection. This work highlights key breakthroughs in the development of enabling technologies that further the goal of personalized and precision medicine, and remaining challenges that, when addressed, may forge unprecedented capabilities in realizing truly individualized patient care.

Published
2020

22. A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia

Author

Krishnan, Vaidehi, Schmidt, Florian, Nawaz, Zahid, Venkatesh, Prasanna Nori, Lee, Kian Leong, Ren, Xi, Chan, Zhu En, Yu, Mengge, Makheja, Meera, Rayan, Nirmala Arul, Lim, Michelle Gek Liang, Cheung, Alice Man Sze, Bari, Sudipto, Chng, Wee Joo, Than, Hein, Ouyang, John, Rackham, Owen, Tan, Tuan Zea, Hwang, William Ying Khee, Chuah, Charles, Prabhakar, Shyam, and Ong, S. Tiong

Published
2023
Full Text
View/download PDF

24. Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Author

Guo, Mingrui, Chan, Tim Hon Man, Zhou, Qiling, An, Omer, Li, Ying, Song, Yangyang, Tan, Zi Hui, Ng, Vanessa Hui En, Peramangalam, Philomina Sona, Tan, Zhi Qing, Cao, Xinang, Iwanaga, Eisaku, Matsuoka, Masao, Ooi, Melissa, Jen, Wei Ying, Koh, Liang Piu, Chan, Esther, Tan, Lip Kun, Goh, Yufen, Wang, Wilson, Koh, Bryan T. H., Chun, Chan Ming, Fullwood, Melissa J., Chng, Wee Joo, Osato, Motomi, Pulikkan, John Anto, Yang, Henry, Chen, Leilei, and Tenen, Daniel G.

Published
2023
Full Text
View/download PDF

25. Pan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis

Author

Chan, Jia Jia, Zhang, Bin, Chew, Xiao Hong, Salhi, Adil, Kwok, Zhi Hao, Lim, Chun You, Desi, Ng, Subramaniam, Nagavidya, Siemens, Angela, Kinanti, Tyas, Ong, Shane, Sanchez-Mejias, Avencia, Ly, Phuong Thao, An, Omer, Sundar, Raghav, Fan, Xiaonan, Wang, Shi, Siew, Bei En, Lee, Kuok Chung, Chong, Choon Seng, Lieske, Bettina, Cheong, Wai-Kit, Goh, Yufen, Fam, Wee Nih, Ooi, Melissa G., Koh, Bryan T. H., Iyer, Shridhar Ganpathi, Ling, Wen Huan, Chen, Jianbin, Yoong, Boon-Koon, Chanwat, Rawisak, Bonney, Glenn Kunnath, Goh, Brian K. P., Zhai, Weiwei, Fullwood, Melissa J., Wang, Wilson, Tan, Ker-Kan, Chng, Wee Joo, Dan, Yock Young, Pitt, Jason J., Roca, Xavier, Guccione, Ernesto, Vardy, Leah A., Chen, Leilei, Gao, Xin, Chow, Pierce K. H., Yang, Henry, and Tay, Yvonne

Published
2022
Full Text
View/download PDF

29. Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)

Author

Rashid, Masturah Bte Mohd Abdul, Toh, Tan Boon, Hooi, Lissa, Silva, Aleidy, Zhang, Yanzhou, Tan, Pei Fang, Teh, Ai Ling, Karnani, Neerja, Jha, Sudhakar, Ho, Chih-Ming, Chng, Wee Joo, Ho, Dean, and Chow, Edward Kai-Hua

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Cancer, Hematology, Orphan Drug, Rare Diseases, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, Animals, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p21, DNA Damage, DNA Methylation, Decitabine, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm, Drug Synergism, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, High-Throughput Screening Assays, Humans, Mice, Mitomycin, Multiple Myeloma, Phenotype, Protein Tyrosine Phosphatase, Non-Receptor Type 6, RNA, Messenger, Tumor Burden, Biological Sciences, Medical and Health Sciences, Medical biotechnology, Biomedical engineering
Abstract

Multiple myeloma is an incurable hematological malignancy that relies on drug combinations for first and secondary lines of treatment. The inclusion of proteasome inhibitors, such as bortezomib, into these combination regimens has improved median survival. Resistance to bortezomib, however, is a common occurrence that ultimately contributes to treatment failure, and there remains a need to identify improved drug combinations. We developed the quadratic phenotypic optimization platform (QPOP) to optimize treatment combinations selected from a candidate pool of 114 approved drugs. QPOP uses quadratic surfaces to model the biological effects of drug combinations to identify effective drug combinations without reference to molecular mechanisms or predetermined drug synergy data. Applying QPOP to bortezomib-resistant multiple myeloma cell lines determined the drug combinations that collectively optimized treatment efficacy. We found that these combinations acted by reversing the DNA methylation and tumor suppressor silencing that often occur after acquired bortezomib resistance in multiple myeloma. Successive application of QPOP on a xenograft mouse model further optimized the dosages of each drug within a given combination while minimizing overall toxicity in vivo, and application of QPOP to ex vivo multiple myeloma patient samples optimized drug combinations in patient-specific contexts.

Published
2018

30. The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens

Author

Blasiak, Agata, Truong, Anh T. L., Remus, Alexandria, Hooi, Lissa, Seah, Shirley Gek Kheng, Wang, Peter, Chye, De Hoe, Lim, Angeline Pei Chiew, Ng, Kim Tien, Teo, Swee Teng, Tan, Yee-Joo, Allen, David Michael, Chai, Louis Yi Ann, Chng, Wee Joo, Lin, Raymond T. P., Lye, David C. B., Wong, John Eu-Li, Tan, Gek-Yen Gladys, Chan, Conrad En Zuo, Chow, Edward Kai-Hua, and Ho, Dean

Published
2022
Full Text
View/download PDF

31. Data from A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy

Author

Lao, Zhentang, primary, Ding, Ling-Wen, primary, Sun, Qiao-Yang, primary, Jia, Li, primary, Yan, Benedict, primary, Ng, Alvin Yu-Jin, primary, Capinpin, Sharah Mae, primary, Wang, Renwei, primary, Ying, Li, primary, Chng, Wee Joo, primary, Koeffler, H. Phillip, primary, Koh, Woon-Puay, primary, Yuan, Jian-Min, primary, Yang, Henry, primary, Goh, Yeow Tee, primary, and Grigoropoulos, Nicholas, primary

Published
2024
Full Text
View/download PDF

32. Figure S11 from Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts

Author

Olesinski, Elyse A., primary, Bhatia, Karanpreet Singh, primary, Wang, Chuqi, primary, Pioso, Marissa S., primary, Lin, Xiao Xian, primary, Mamdouh, Ahmed M., primary, Ng, Shu Xuan, primary, Sandhu, Vedant, primary, Jasdanwala, Shaista Shabbir, primary, Yilma, Binyam, primary, Bohl, Stephan, primary, Ryan, Jeremy A., primary, Malani, Disha, primary, Luskin, Marlise R., primary, Kallioniemi, Olli, primary, Porkka, Kimmo, primary, Adamia, Sophia, primary, Chng, Wee Joo, primary, Osato, Motomi, primary, Weinstock, David M., primary, Garcia, Jacqueline S., primary, Letai, Anthony, primary, and Bhatt, Shruti, primary

Published
2024
Full Text
View/download PDF

33. Data from Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts

Author

Olesinski, Elyse A., primary, Bhatia, Karanpreet Singh, primary, Wang, Chuqi, primary, Pioso, Marissa S., primary, Lin, Xiao Xian, primary, Mamdouh, Ahmed M., primary, Ng, Shu Xuan, primary, Sandhu, Vedant, primary, Jasdanwala, Shaista Shabbir, primary, Yilma, Binyam, primary, Bohl, Stephan, primary, Ryan, Jeremy A., primary, Malani, Disha, primary, Luskin, Marlise R., primary, Kallioniemi, Olli, primary, Porkka, Kimmo, primary, Adamia, Sophia, primary, Chng, Wee Joo, primary, Osato, Motomi, primary, Weinstock, David M., primary, Garcia, Jacqueline S., primary, Letai, Anthony, primary, and Bhatt, Shruti, primary

Published
2024
Full Text
View/download PDF

36. Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma

Author

Sridhar, Shruti, primary, Hoppe, Michal Marek, additional, Liu, Min, additional, Jaynes, Patrick, additional, Peng, Yanfen, additional, De Mel, Sanjay, additional, Poon, Limei, additional, Chan, Esther Hian Li, additional, Lee, Joanne, additional, Nagarajan, Chandramouli, additional, Grigoropoulos, Nicholas F., additional, Tan, Soo-Yong, additional, Hue, Susan Swee-Shan, additional, Li, Shaoying, additional, Khoury, Joseph D., additional, Farinha, Pedro, additional, Mottok, Anja, additional, Scott, David W., additional, Kumar, Gayatri, additional, Kannan, Kasthuri, additional, Chng, Wee Joo, additional, Chee, Yen Lin, additional, Ng, Siok-Bian, additional, Tripodo, Claudio, additional, and Jeyasekharan, Anand D., additional

Published
2024
Full Text
View/download PDF

38. Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma

Author

Lee, Wendy W. L., primary, Lim, Jing Quan, additional, Tang, Tiffany P. L., additional, Tan, Daryl, additional, Koh, Ser Mei, additional, Puan, Kia Joo, additional, Wang, Liang Wei, additional, Lim, Jackwee, additional, Tan, Kim Peng, additional, Chng, Wee Joo, additional, Lim, Soon Thye, additional, Ong, Choon Kiat, additional, and Rotzschke, Olaf, additional

Published
2024
Full Text
View/download PDF

42. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

Author

Moreau, Philippe, Kumar, Shaji K, San Miguel, Jesús, Davies, Faith, Zamagni, Elena, Bahlis, Nizar, Ludwig, Heinz, Mikhael, Joseph, Terpos, Evangelos, Schjesvold, Fredrik, Martin, Thomas, Yong, Kwee, Durie, Brian G M, Facon, Thierry, Jurczyszyn, Artur, Sidana, Surbhi, Raje, Noopur, van de Donk, Niels, Lonial, Sagar, Cavo, Michele, Kristinsson, Sigurdur Y, Lentzsch, Suzanne, Hajek, Roman, Anderson, Kenneth C, João, Cristina, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika, Fonseca, Rafael, Vangsted, Annette, Weisel, Katja, Baz, Rachid, Hungria, Vania, Berdeja, Jesus G, Leal da Costa, Fernando, Maiolino, Angelo, Waage, Anders, Vesole, David H, Ocio, Enrique M, Quach, Hang, Driessen, Christoph, Bladé, Joan, Leleu, Xavier, Riva, Eloisa, Bergsagel, Peter Leif, Hou, Jian, Chng, Wee Joo, Mellqvist, Ulf-Henrik, Dytfeld, Dominik, Harousseau, Jean-Luc, Goldschmidt, Hartmut, Laubach, Jacob, Munshi, Nikhil C, Gay, Francesca, Beksac, Meral, Costa, Luciano J, Kaiser, Martin, Hari, Parameswaran, Boccadoro, Mario, Usmani, Saad Z, Zweegman, Sonja, Holstein, Sarah, Sezer, Orhan, Harrison, Simon, Nahi, Hareth, Cook, Gordon, Mateos, Maria-Victoria, Rajkumar, S Vincent, Dimopoulos, Meletios A, and Richardson, Paul G

Published
2021
Full Text
View/download PDF

47. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations

Author

Au, Wing-Yan, Chiu, Brian, Fan, Lei, Li, Zheng, LAM, Tai Hing, Liang, Raymond, Yeh, Su-Peng, Xu, Jun, Ip, Dennis Kai Ming, Li, Gandi, Xu, Gang, Wang, Xiaodong, Bai, Ou, Cai, Qing-Qing, Xia, Yi, Chen, Jie-Rong, Luo, Chun-Ling, Xiong, Xiang-Yu, Zeng, Yanni, Wei, Pan-Pan, Liu, Chu-Jun, Liu, Yu-Xiang, Cao, Yu-Lu, He, Shuai, Liu, Yang, Ha, Jeslin Chian Hung, Khoo, Lay Poh, Kee, Rebecca Xiangpin, Tan, Jing, Liu, Yanhui, Zhang, Fen, Feng, Yanfen, Rao, Huilan, Chng, Wee Joo, Chan, Jason Yong Sheng, Somasundaram, Nagavalli D/O, Tao, Miriam, Ras, Mohamad Farid Bin Harunal, Yeoh, Kheng-Wei, Goh, Yeow Tee, Ong, Shin Yeu, Grigoropoulos, Nicholas Francis, Wong, Esther Kam Yin, Pang, Jane Wan Lu, Lim, Jing Quan, Chia, Burton Kuan Hui, Kim, Seok Jin, Yoon, Sang Eun, Choi, Seungkyu, Kuo, Ching-Yuan, Chen, Tsai-Yun, Su, Yu-Chieh, Huang, Wen-Tsung, Lee, Ming-Yang, Yao, Wenxiu, Ngan, Kai-Cheong, Liu, Herman, Lee, Harold, Yip, Sze-Fai, Liu, Jie, Li, Jianyong, Rabkin, Charles S., Berndt, Sonja, Bassig, Bryan, Hu, Wei, Zhao, Mingfeng, Li, Yuming, Zhai, Qiongli, Shao, Zonghong, Qiu, Lugui, Wang, Jianxiang, Xu, Fu-Ping, Chen, Ling, Hou, Yu, Xu, Shuangnian, Huang, Zhen, Xie, Mingling, Li, Ming, Zhong, Shilong, Zhang, Yan, Gu, Dongqing, Wang, Xin, Foo, Jia Nee, Li, Zhiqiang, Dai, Juncheng, Sun, Liangdan, Wang, Zhenzhen, Liu, Hong, Zhou, Hui, Sun, Yonghu, Koh, Woon-Puay, Heng, Chew-Kiat, Hong, Chew Soo, Ahn, Jeeyun, Park, Kyu Hyung, Tin, Aung, Gu, Jieruo, Xia, Xiaojun, Li, Bo, Yu, Xueqing, Lin, Guo-Wang, Xu, Caigang, Chen, Kexin, Huang, Hui-Qiang, Chen, Jieping, Song, Bao, Chan, John K C, Li, Wenyu, Liu, Weiping, Shih, Lee-Yung, Chuang, Wen-Yu, Kim, Won Seog, Tan, Wen, Peng, Rou-Jun, Laurensia, Yurike, Cheah, Daryl Ming Zhe, Huang, DaChuan, Cheng, Chee Leong, Su, Yi-Jiun, Tan, Soo-Yong, Ng, Siok-Bian, Tang, Tiffany Pooi Ling, Han, Kyudong, Wang, Vivien Ya-Fan, Jia, Wei-Hua, Pei, Zhong, Li, Ya-Jun, Gao, Song, Shi, Yongyong, Hu, Zhibin, Zhang, Furen, Zhang, Ben, Zeng, Yi-Xin, Shen, Hongbing, He, Lin, Ong, Choon Kiat, Lim, Soon Thye, Chanock, Stephen, Kwong, Yok-Lam, Lin, Dongxin, Rothman, Nathaniel, Khor, Chiea Chuen, Lan, Qing, and Bei, Jin-Xin

Published
2020
Full Text
View/download PDF

48. A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy

Author

Lao, Zhentang, primary, Ding, Ling-Wen, additional, Sun, Qiao-Yang, additional, Jia, Li, additional, Yan, Benedict, additional, Ng, Alvin Yu-Jin., additional, Capinpin, Sharah Mae., additional, Wang, Renwei, additional, Ying, Li, additional, Chng, Wee Joo, additional, Koeffler, H. Phillip, additional, Koh, Woon-Puay, additional, Yuan, Jian-Min, additional, Yang, Henry, additional, Goh, Yeow Tee, additional, and Grigoropoulos, Nicholas, additional

Published
2024
Full Text
View/download PDF

49. Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.

Author

Ninkovic, Slavisa, primary, Harrison, Simon J, additional, Lee, Je-Jung, additional, Murphy, Nick, additional, Lee, Jae Hoon, additional, Estell, Jane, additional, Chen, Vivien M, additional, Horvath, Noemi, additional, Kim, Kihuyn, additional, Eek, Richard, additional, Augustson, Bradley, additional, Bang, Soo-Mee, additional, Huang, Shang-Yi, additional, Rajagopal, Rajeev, additional, Szabo, Ferenc, additional, Engeler, Daniel, additional, Butcher, Belinda E, additional, Mollee, Peter, additional, Durie, Brian, additional, Chng, Wee Joo, additional, and Quach, Hang, additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results